<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Cytokines and inflammation</journal-id><journal-title-group><journal-title xml:lang="en">Cytokines and inflammation</journal-title><trans-title-group xml:lang="ru"><trans-title>Цитокины и воспаление</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1684-7849</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">627071</article-id><article-id pub-id-type="doi">10.17816/CI627071</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Original Study Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Оригинальные исследования</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Effects of peptide L2 of human papillomavirus type 16 on the cytokine profile of dendritic cells in vitro</article-title><trans-title-group xml:lang="ru"><trans-title>Влияние пептида L2 вируса папилломы человека 16-го типа на цитокиновый профиль дендритных клеток in vitro</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5467-0702</contrib-id><contrib-id contrib-id-type="spin">9153-5103</contrib-id><name-alternatives><name xml:lang="en"><surname>Boeva</surname><given-names>Ksenia A.</given-names></name><name xml:lang="ru"><surname>Боева</surname><given-names>Ксения Эльбертовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Junior Researcher</p></bio><bio xml:lang="ru"><p>младший научный сотрудник</p></bio><email>boeva_ke@niivirom.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1259-8850</contrib-id><contrib-id contrib-id-type="spin">4161-0999</contrib-id><name-alternatives><name xml:lang="en"><surname>Malyshkina</surname><given-names>Galina V.</given-names></name><name xml:lang="ru"><surname>Малышкина</surname><given-names>Галина Владимировна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Junior Researcher</p></bio><bio xml:lang="ru"><p>младший научный сотрудник</p></bio><email>malyshkina_gv@niivirom.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3123-8359</contrib-id><contrib-id contrib-id-type="spin">9107-4118</contrib-id><name-alternatives><name xml:lang="en"><surname>Vyalykh</surname><given-names>Ivan V.</given-names></name><name xml:lang="ru"><surname>Вялых</surname><given-names>Иван Владимирович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Veterinary), Leading Researcher</p></bio><bio xml:lang="ru"><p>канд. ветеринар. наук, ведущий научный сотрудник</p></bio><email>vyalykh_iv@niivirom.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Federal Scientific Research Institute of Viral Infections “Virome”</institution></aff><aff><institution xml:lang="ru">Федеральный научно-исследовательский институт вирусных инфекций «Виром»</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2024-04-22" publication-format="electronic"><day>22</day><month>04</month><year>2024</year></pub-date><pub-date date-type="pub" iso-8601-date="2023-12-18" publication-format="electronic"><day>18</day><month>12</month><year>2023</year></pub-date><volume>20</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>24</fpage><lpage>30</lpage><history><date date-type="received" iso-8601-date="2024-02-16"><day>16</day><month>02</month><year>2024</year></date><date date-type="accepted" iso-8601-date="2024-04-02"><day>02</day><month>04</month><year>2024</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2023, Boeva K.A., Malyshkina G.V., Vyalykh I.V.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2023, Боева К.Э., Малышкина Г.В., Вялых И.В.</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="en">Boeva K.A., Malyshkina G.V., Vyalykh I.V.</copyright-holder><copyright-holder xml:lang="ru">Боева К.Э., Малышкина Г.В., Вялых И.В.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2026-05-18"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-nd/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://cijournal.ru/1684-7849/article/view/627071">https://cijournal.ru/1684-7849/article/view/627071</self-uri><abstract xml:lang="en"><p><bold>BACKGROUND:</bold><italic> </italic>The human papillomavirus is an etiological factor and a biological carcinogen in tumor lesions and cancer. Currently, there are several known possible mechanisms of immune evasion of human papillomavirus. Therefore, early methods for diagnosing papillomavirus infection and effective treatments.</p> <p><bold>AIM:</bold><italic> </italic>To analyze the cytokine profile should be established of dendritic cells in response should be determined to stimulation by peptide L2 of human papillomavirus type 16 <italic>in vitro</italic>.</p> <p><bold>METHODS:</bold><italic> </italic>Dendritic cell cultures were obtained from the blood of donors without signs of the human papillomavirus infection in history. A culture without stimulation was used as a control. As experimental groups, cultures synthesized peptide with L2 of the human papillomavirus type 16 were used. Enzyme-linked immunosorbent assay was used to determine the levels of pro- and anti-inflammatory cytokines.</p> <p><bold>RESULTS:</bold><italic> </italic>In comparison with spontaneous response in the control group after inoculation with peptide L2 of human papillomavirus type 16, increased IL-10, MCP-1, VEGF, IL-6, and IFN-γ concentrations and significant changes in IL-1β, IL-4, IL-8, IFN-α, and TNF-α concentrations were not detected.</p> <p><bold>CONCLUSIONS:</bold><italic> </italic>The results confirm the ability of the human papillomavirus to evade the antiviral immune response by affecting the synthesis of several cytokines.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Обоснование.</bold> Вирус папилломы человека является этиологическим фактором и биологическим канцерогеном при опухолевых поражениях и раке. В настоящее время известно множество возможных механизмов иммунной эвазии вирусов. По-прежнему существует необходимость в расширении ранних методов диагностики инфицирования вирусом папилломы человека и поиска эффективных методов лечения.</p> <p><bold>Цель исследования </bold>— изучение цитокинового профиля дендритных клеток в ответ на стимуляцию пептидом L2 вируса папилломы человека 16-го типа <italic>in vitro</italic>.</p> <p><bold>Методы.</bold> Культуры дендритных клеток получали из образцов крови доноров, не имеющих в анамнезе признаков инфицирования вирусом папилломы человека. В качестве контроля использовали культуру без стимуляции пептидом. В качестве экспериментальных групп — культуры, в которые вносили синтезированный свободный пептид L2 вируса папилломы человека 16-го типа. Количество про- и противовоспалительных цитокинов определяли методом иммуноферментного анализа.</p> <p><bold>Результаты.</bold> После внесения пептида L2 вируса папилломы человека 16-го типа в сравнении со спонтанным ответом в контрольной группе регистрировали увеличение концентрации IL-10, МСР-1, VEGF, IL-6, IFN-γ, достоверно значимого изменения концентрации IL-1β, IL-4 и IL-8, IFN-α, TNF-α не происходило.</p> <p><bold>Заключение.</bold> Полученные результаты подтверждают способность вируса папилломы человека к уклонению от противовирусного иммунного ответа организма путём воздействия на синтез ряда цитокинов.</p></trans-abstract><kwd-group xml:lang="en"><kwd>human papillomavirus</kwd><kwd>cytokines</kwd><kwd>chemokines</kwd><kwd>immune evasion</kwd><kwd>vascular endothelial growth factor</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>вирус папилломы человека</kwd><kwd>цитокины</kwd><kwd>хемокины</kwd><kwd>иммунная эвазия</kwd><kwd>фактор роста эндотелия сосудов</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution xml:lang="ru">«Изучение эффективности клеточного иммунного ответа у ВИЧ-позитивных лиц, инфицированных вирусом папилломы человека»</institution></institution-wrap><institution-wrap><institution xml:lang="en">“Study of the effectiveness of cellular immune response in HIV-positive individuals infected with human papillomavirus”</institution></institution-wrap></funding-source><award-id>122040600157-0</award-id></award-group></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">Ntanasis-Stathopoulos I, Kyriazoglou A, Liontos M, Dimopoulos MA, Gavriatopoulou M. Current trends in the management and prevention of human papillomavirus (HPV) infection. J BUON. 2020;25(3):1281–1285.</mixed-citation><mixed-citation xml:lang="ru">Ntanasis-Stathopoulos I., Kyriazoglou A., Liontos M., Dimopoulos M.A., Gavriatopoulou M. Current trends in the management and prevention of human papillomavirus (HPV) infection // J BUON. 2020. Vol. 25, N 3. P. 1281–1285.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">Hong S, Laimins LA. Manipulation of the innate immune response by human papillomaviruses. Virus Research. 2017;231:34–40. doi: 10.1016/j.virusres.2016.11.004</mixed-citation><mixed-citation xml:lang="ru">Hong S., Laimins L.A. Manipulation of the innate immune response by human papillomaviruses // Virus Research. 2017. Vol. 231. P. 34–40. doi: 10.1016/j.virusres.2016.11.004</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">Lefkowitz EJ, Dempsey DM, Hendrickson RC, et al. Virus taxonomy: the database of the International Committee on Taxonomy of Viruses (ICTV). Nucleic Acids Research. 2018;46(D1):D708–D717. doi: 10.1093/nar/gkx932</mixed-citation><mixed-citation xml:lang="ru">Lefkowitz E.J., Dempsey D.M., Hendrickson R.C., et al. Virus taxonomy: the database of the International Committee on Taxonomy of Viruses (ICTV) // Nucleic Acids Research. 2018. Vol. 46, N D1. P. D708–D717. doi: 10.1093/nar/gkx932</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">Brockmann L, Soukou S, Steglich B, Czarnewski P. Molecular and functional heterogeneity of IL-10-producing CD4+ T cells. Nature Communications. 2018;9(1):5457. doi: 10.1038/s41467-018-07581-4</mixed-citation><mixed-citation xml:lang="ru">Brockmann L., Soukou S., Steglich B., Czarnewski P. Molecular and functional heterogeneity of IL-10-producing CD4+ T cells // Nature Communications. 2018. Vol. 9, N 1. P. 5457. doi: 10.1038/s41467-018-07581-4</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">Rojas-Sepúlveda DA, Gleisner A, Pereda C, López M, Onfray FS. Tumor lysate loaded dendritic cells induce a Tcell specific antitumor response against gallbladder cancer. Journal of Immunology. 2017;198 Suppl. 1(79):18–79. doi: 10.4049/jimmunol.198.Supp.79.18</mixed-citation><mixed-citation xml:lang="ru">Rojas-Sepúlveda D.A., Gleisner A., Pereda C., López M., Onfray F.S. Tumor lysate loaded dendritic cells induce a T cell specific antitumor response against gallbladder cancer // Journal of Immunology. 2017. Vol. 198, Suppl. 1, N 79. P. 18–79. doi: 10.4049/jimmunol.198.Supp.79.18</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">Skelin J, Sabol I, Tomaić V. Do or Die: HPV E5, E6 and E7 in Cell Death Evasion. Pathogens. 2022;11(9):1027. doi: 10.3390/pathogens11091027</mixed-citation><mixed-citation xml:lang="ru">Skelin J., Sabol I., Tomaić V. Do or Die: HPV E5, E6 and E7 in Cell Death Evasion // Pathogens. 2022. Vol. 11, N 9. P. 1027. doi: 10.3390/pathogens11091027</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">Garg AD, Vara Perez M, Schaaf M, et al. Trial watch: Dendritic cell-based anticancer immunotherapy. Europe PMC. 2017;6(7): e1328341. doi: 10.1080/2162402X.2017.1328341</mixed-citation><mixed-citation xml:lang="ru">Garg A.D., Vara Perez M., Schaaf M., et al. Trial watch: Dendritic cell-based anticancer immunotherapy // Europe PMC. 2017. Vol. 6, N 7. P. e1328341. doi: 10.1080/2162402X.2017.1328341</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">Gutiérrez-Hoya A, Soto-Cruz I. NK Cell Regulation in Cervical Cancer and Strategies for Immunotherapy. Cells. 2021;10(11):3104. doi: 10.3390/cells10113104</mixed-citation><mixed-citation xml:lang="ru">Gutiérrez-Hoya A., Soto-Cruz I. NK Cell Regulation in Cervical Cancer and Strategies for Immunotherapy // Cells. 2021. Vol. 10, N 11. P. 3104. doi: 10.3390/cells10113104</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">Nakayama T, Kashiwagi Y, Kawashima H. Long-term regulation of local cytokine production following immunization in mice. Medical Microbiology and Immunology. 2018;62(2):124–131. doi: 10.1111/1348-0421.12566</mixed-citation><mixed-citation xml:lang="ru">Nakayama T., Kashiwagi Y., Kawashima H. Long-term regulation of local cytokine production following immunization in mice // Medical Microbiology and Immunology. 2018. Vol. 62, N 2. N 124–131. doi: 10.1111/1348-0421.12566</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">Zhou B, Lawrence T, Liang Y. The Role of Plasmacytoid Dendritic Cells in Cancers. Frontiers in Immunology. 2021;12:749190. doi: 10.3389/fimmu.2021.749190</mixed-citation><mixed-citation xml:lang="ru">Zhou B., Lawrence T., Liang Y. The Role of Plasmacytoid Dendritic Cells in Cancers // Frontiers in Immunology. 2021. Vol. 12. P. 749190. doi: 10.3389/fimmu.2021.749190</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">Bryant C, Fromm PD, Kupresanin F, et al. A CD2 high-expressing stress-resistant human plasmacytoid dendritic-cell subset. Immunology and Cell Biology. 2016;94(5):447–457. doi: 10.1038/icb.2015.116</mixed-citation><mixed-citation xml:lang="ru">Bryant C., Fromm P.D., Kupresanin F., et al. A CD2 high-expressing stress-resistant human plasmacytoid dendritic-cell subset // Immunology and Cell Biology. 2016. Vol. 94, N 5. P. 447–457. doi: 10.1038/icb.2015.116</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">Mahendra INB, Prayudi PKA., Putra Dwija IBN, Suwiyoga K. HPV16-E6/E7 Oncogene Mutation and p53 Expression among Indonesian women with cervical Cancer. Asian Pacific Journal of Cancer Prevention. 2022;23(8):2705–2711. doi: 10.31557/APJCP.2022.23.8.2705</mixed-citation><mixed-citation xml:lang="ru">Mahendra I.N.B., Prayudi P.K.A., Putra Dwija I.B.N., Suwiyoga K. HPV16-E6/E7 Oncogene Mutation and p53 Expression among Indonesian women with cervical Cancer // Asian Pacific Journal of Cancer Prevention. 2022. Vol. 23, N 8. P. 2705–2711. doi: 10.31557/APJCP.2022.23.8.2705</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">Boyum A. Separation of leukocytes from blood and bone marrow. Scandinavian Journal of Clinical and Laboratory Investigation. 1968;21 Suppl. 97:77–89.</mixed-citation><mixed-citation xml:lang="ru">Boyum A. Separation of leukocytes from blood and bone marrow // Scandinavian Journal of Clinical and Laboratory Investigation. 1968. Vol. 21, Suppl. 97. P. 77–89.</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">Sadri Nahand J, Moghoofei M, Salmaninejad A, et al. Pathogenic role of exosomes and microRNAs in HPV-mediated inflammation and cervical cancer: A review. International Journal of Cancer. 2020;146(2):305–320. doi: 10.1002/ijc.32688</mixed-citation><mixed-citation xml:lang="ru">Sadri Nahand J., Moghoofei M., Salmaninejad A., et al. Pathogenic role of exosomes and microRNAs in HPV-mediated inflammation and cervical cancer: A review // International Journal of Cancer. 2020. Vol. 146, N 2. P. 305–320. doi: 10.1002/ijc.32688</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">Kleine-Lowinski K, Rheinwald JG, Fichorova RN, et al. Selective suppression of monocyte chemoattractant protein-1 expression by human papillomavirus E6 and E7 oncoproteins in human cervical epithelial and epidermal cells. International Journal of Cancer. 2003;107(3):407–415. doi: 10.1002/ijc.11411</mixed-citation><mixed-citation xml:lang="ru">Kleine-Lowinski K., Rheinwald J.G., Fichorova R.N., et al. Selective suppression of monocyte chemoattractant protein-1 expression by human papillomavirus E6 and E7 oncoproteins in human cervical epithelial and epidermal cells // International Journal of Cancer. 2003. Vol. 107, N 3. P. 407–415. doi: 10.1002/ijc.11411</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">Yang X, Cheng Y, Li C. The role of TLRs in cervical cancer with HPV infection: a review. Signal Transduction and Targeted Therapy. 2017;2:17055. doi: 10.1038/sigtrans.2017.55</mixed-citation><mixed-citation xml:lang="ru">Yang X., Cheng Y., Li C. The role of TLRs in cervical cancer with HPV infection: a review // Signal Transduction and Targeted Therapy. 2017. Vol. 2. P. 17055. doi: 10.1038/sigtrans.2017.55</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">Song SH, Lee JK, Seok OS, Saw HS. The relationship between cytokines and HPV-16, HPV-16 E6, E7, and high-risk HPV viral load in the uterine cervix. Gynecologic Oncology. 2007;104(3):732–738. doi: 10.1016/j.ygyno.2006.10.054</mixed-citation><mixed-citation xml:lang="ru">Song S.-H., Lee J.K., Seok O.-S., Saw H.-S. The relationship between cytokines and HPV-16, HPV-16 E6, E7, and high-risk HPV viral load in the uterine cervix // Gynecologic Oncology. 2007. Vol. 104, N 3. P. 732–738. doi: 10.1016/j.ygyno.2006.10.054</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">Yuan Y, Min SJ, Xu DQ, et al. Expressions of VEGF and miR-21 in tumor tissues of cervical cancer patients with HPV infection and their relationships with prognosis. European Review for Medical and Pharmacological Science. 2018;22(19):6274–6279. doi: 10.26355/eurrev_201810_16035</mixed-citation><mixed-citation xml:lang="ru">Yuan Y., Min S.-J., Xu D.-Q., et al. Expressions of VEGF and miR-21 in tumor tissues of cervical cancer patients with HPV infection and their relationships with prognosis // European Review for Medical and Pharmacological Science. 2018. Vol. 22, N 19. P. 6274–6279. doi: 10.26355/eurrev_201810_16035</mixed-citation></citation-alternatives></ref></ref-list></back></article>
